Terms of use

esp360.ca presents research and conference material relating to ESP360°, a decision-provenance architecture developed by Mark E. Paull. Using this site means accepting the following.

Status of the material

Everything published here is presentation and discussion material. It is not medical advice, not a clinical decision aid, and not a product. Nothing on this site should be used to make or justify a treatment decision for any person.

Research figures and embargo

Dataset figures shown publicly are those verified against the master workbook after conference submission. Accepted abstract content for the Breakthrough T1D Clinical & Research Congress 2026 remains under the congress publication embargo until 9 October 2026 and is deliberately withheld from this site until that date.

Intellectual property

The ESP360° name, the written material on this site and the underlying architecture are the property of Mark E. Paull. Two United States provisional patent applications have been filed. Implementation detail is deliberately withheld. You may quote short passages with attribution; you may not reproduce the site's material in bulk or present it as your own.

The audio message feature

By sending a recording you confirm that it is your own voice or that you have the speaker's permission, that it contains no third party's identifiable health information, and that you have read how it is stored and for how long. Submissions that are abusive or automated are discarded. Recordings are not monitored and no response time is guaranteed.

Availability

The site is provided as it is, without warranty of availability or fitness for any purpose. Links to external sites are provided for reference and are not endorsements.

Governing law

These terms are governed by the laws of the Province of Québec and the laws of Canada applicable there.

Last updated 30 August 2026.